Thomas Heineman
Chief Tech/Sci/R&D Officer presso ONCOLYTICS BIOTECH INC.
Patrimonio netto: 547 172 $ in data 31/03/2024
Profilo
Thomas C Heineman is currently the Chief Medical Officer at Oncolytics Biotech, Inc. He previously worked as the Senior Director-Clinical Research & Development at GSK Plc from 2006 to 2016.
He also held the position of Associate Professor at Saint Louis University School of Medicine.
From 2018 to 2020, he served as the Vice President & Head-Clinical Development at Halozyme Therapeutics, Inc. Additionally, he was the SVP & Head-Clinical Development at Denovo Biopharma LLC in 2020.
From 2016 to 2020, he worked as the Vice President & Head-Clinical Development at Genocea Biosciences, Inc. Dr. Heineman holds graduate and doctorate degrees from The University of Chicago.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC.
0.68% | 07/03/2024 | 516 200 ( 0.68% ) | 547 172 $ | 31/03/2024 |
Posizioni attive di Thomas Heineman
| Società | Posizione | Inizio |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Chief Tech/Sci/R&D Officer | 01/08/2020 |
Precedenti posizioni note di Thomas Heineman
| Società | Posizione | Fine |
|---|---|---|
Denovo Biopharma LLC
 Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/07/2020 |
| GENOCEA BIOSCIENCES, INC. | Corporate Officer/Principal | 01/01/2020 |
| HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01/08/2016 |
| Saint Louis University School of Medicine | Corporate Officer/Principal | - |
Formazione di Thomas Heineman
| The University of Chicago | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| ONCOLYTICS BIOTECH INC. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| GSK PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Denovo Biopharma LLC
Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Thomas Heineman
